The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity

Rita M. Tavares, Emre E. Turer, Chih L. Liu, Rommel Advincula, Patrizia Scapini, Lesley Rhee, Julio Barrera, Clifford A. Lowell, Paul J. Utz, Barbara A. Malynn, Averil Ma

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

A20 is a ubiquitin modifying enzyme that restricts NF-κB signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20's roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-κB responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-κB-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.

Original languageEnglish (US)
Pages (from-to)181-191
Number of pages11
JournalImmunity
Volume33
Issue number2
DOIs
StatePublished - Aug 1 2010

Fingerprint

Ubiquitin
Autoimmunity
Cell Survival
B-Lymphocytes
Enzymes
Cell Death
Tumor Necrosis Factor-alpha
Germinal Center
B-Cell Lymphoma
Systemic Lupus Erythematosus
Autoantibodies
Immunoglobulins
Alleles
Proteins

Keywords

  • Cellimmuno
  • Molimmuno
  • Signaling

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Tavares, R. M., Turer, E. E., Liu, C. L., Advincula, R., Scapini, P., Rhee, L., ... Ma, A. (2010). The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity. Immunity, 33(2), 181-191. https://doi.org/10.1016/j.immuni.2010.07.017

The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity. / Tavares, Rita M.; Turer, Emre E.; Liu, Chih L.; Advincula, Rommel; Scapini, Patrizia; Rhee, Lesley; Barrera, Julio; Lowell, Clifford A.; Utz, Paul J.; Malynn, Barbara A.; Ma, Averil.

In: Immunity, Vol. 33, No. 2, 01.08.2010, p. 181-191.

Research output: Contribution to journalArticle

Tavares, RM, Turer, EE, Liu, CL, Advincula, R, Scapini, P, Rhee, L, Barrera, J, Lowell, CA, Utz, PJ, Malynn, BA & Ma, A 2010, 'The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity', Immunity, vol. 33, no. 2, pp. 181-191. https://doi.org/10.1016/j.immuni.2010.07.017
Tavares, Rita M. ; Turer, Emre E. ; Liu, Chih L. ; Advincula, Rommel ; Scapini, Patrizia ; Rhee, Lesley ; Barrera, Julio ; Lowell, Clifford A. ; Utz, Paul J. ; Malynn, Barbara A. ; Ma, Averil. / The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity. In: Immunity. 2010 ; Vol. 33, No. 2. pp. 181-191.
@article{115ac2da38914e988370e44c40e4da3c,
title = "The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity",
abstract = "A20 is a ubiquitin modifying enzyme that restricts NF-κB signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20's roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-κB responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-κB-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.",
keywords = "Cellimmuno, Molimmuno, Signaling",
author = "Tavares, {Rita M.} and Turer, {Emre E.} and Liu, {Chih L.} and Rommel Advincula and Patrizia Scapini and Lesley Rhee and Julio Barrera and Lowell, {Clifford A.} and Utz, {Paul J.} and Malynn, {Barbara A.} and Averil Ma",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.immuni.2010.07.017",
language = "English (US)",
volume = "33",
pages = "181--191",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity

AU - Tavares, Rita M.

AU - Turer, Emre E.

AU - Liu, Chih L.

AU - Advincula, Rommel

AU - Scapini, Patrizia

AU - Rhee, Lesley

AU - Barrera, Julio

AU - Lowell, Clifford A.

AU - Utz, Paul J.

AU - Malynn, Barbara A.

AU - Ma, Averil

PY - 2010/8/1

Y1 - 2010/8/1

N2 - A20 is a ubiquitin modifying enzyme that restricts NF-κB signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20's roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-κB responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-κB-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.

AB - A20 is a ubiquitin modifying enzyme that restricts NF-κB signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20's roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-κB responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-κB-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.

KW - Cellimmuno

KW - Molimmuno

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=77955917771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955917771&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2010.07.017

DO - 10.1016/j.immuni.2010.07.017

M3 - Article

VL - 33

SP - 181

EP - 191

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 2

ER -